ContextVision AB – Mandatory notification of trade

Stockholm, December 23rd, 2015

Anita Tollstadius, CEO and primary insider in ContextVision AB, has between December 18th and December 23rd 2015 purchased 5 000 shares in ContextVision AB at an average price of NOK 25,67 per share. Following this transaction, Anita Tollstadius owns 5 000 shares in ContextVision AB. Anita Tollstadius also owns 10 000 shares through her 100% owned company Tollstadius & Co AB.

“ContextVision has developed very well during 2015 and I am very optimistic about our future” comments Anita Tollstadius.

For inquires please contact CEO Anita Tollstadius; anita.tollstadius@contextvision.se

This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act.

About ContextVision
ContextVision’s cutting-edge technology helps doctors more accurately interpret medical images, a crucial foundation for better diagnosis and treatment. An industry pioneer for more than 30 years, the company’s state-of-the-art medical image analysis and enhancement software for 2D/3D/4D Ultrasound, MRI, X-Ray and Mammography is used by leading equipment manufacturers worldwide. ContextVision continues to invest heavily in R&D in order to expand its technology platform. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.

Download pdf »